Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol

Sitbon, O ; McLaughlin, V V ; Badesch, D B ; Barst, R J ; Black, C ; Galiè, N ; Humbert, M ; Rainisio, M ; Rubin, L J ; Simonneau, G

Thorax, 2005-12, Vol.60 (12), p.1025-1030 [Periódico revisado por pares]

London: BMJ Publishing Group Ltd and British Thoracic Society

Texto completo disponível